Allogene Therapeutics
Kate Nourse Walker has over 16 years of experience in the field of human resources. Kate currently holds the position of Executive Director of Human Resources at Allogene Therapeutics since November 2022. Prior to that, they worked as a Human Resources Consultant for Allogene Therapeutics from May 2018 to November 2022. Kate also served as a Human Resources Consultant at Opna Bio, CuraSen Therapeutics, Inc., Ambagon Therapeutics, Plexxikon Inc., Kite Pharma, and Afferent Pharmaceuticals. Additionally, they held the role of CEO and Human Resources Consultant at Hamilton Sierra, Inc. and was the Director of HR/Expedia, Inc. at Hotwire. Kate began their career as an HR Business Partner at Expedia, Inc. in 2005.
Kate Nourse Walker obtained their Bachelor of Arts degree in Political Science & International Relations from UC Santa Barbara, completing their education from 1992 to 1996.
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.